Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients
Status:
Recruiting
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of BiRd regimen combined
with BCMA CAR T cell therapy in newly diagnosed multiple myeloma patients
Phase:
Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University
Collaborators:
Affiliated Hospital of Jiangnan University Changshu Frist People's Hospital Huai'an Second People's Hospital Jiangsu Province Hospital of Traditional Chinese Medicine Jiangyin People's Hospital Jingjiang People's Hospital Lianyungang Hospital Affiliated Bengbu Medical College Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd Suzhou Municipal Hospital The first Affiliated Hospital of Nanjing University Medical School The First Affiliated Hospital with Nanjing Medical University The Third People's Hospital of Kunshan Zhangjiagang First People's Hospital